Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Rohit Mehra"'
Publikováno v:
Human Pathology. 133:115-125
Publikováno v:
Human Pathology. 127:112-122
Neuroendocrine tumors of the prostate are rare and encompass a group of entities that are classified based on a combination of morphological and immunohistochemical features. Despite the 2016 World Health Organization classification of prostatic neur
Autor:
Steven B. Goldenthal, Melissa A. Reimers, Udit Singhal, Mark Farha, Rohit Mehra, Morand Piert, Jeffrey J. Tosoian, Parth K. Modi, Nicole Curci, James Peabody, Eduardo Kleer, David C. Smith, Todd M. Morgan
Publikováno v:
Urology. 167:171-178
To aid in the diagnosis and treatment of patients with metastatic tumor seeding, an exceedingly rare phenomenon following minimally invasive urological surgery, additional case reports are needed.We report our experience with patients determined to h
Autor:
Brittney H. Cotta, Toni K. Choueiri, Marcin Cieslik, Pooja Ghatalia, Rohit Mehra, Todd M. Morgan, Ganesh S. Palapattu, Brian Shuch, Ulka Vaishampayan, Eliezer Van Allen, A. Ari Hakimi, Simpa S. Salami
Publikováno v:
European Urology.
Autor:
Kristine M. Cornejo, Ankur R. Sangoi, Andres M. Acosta, Stephanie Siegmund, Rohit Mehra, Michelle S. Hirsch, Lynette M. Sholl, Christopher N. Otis
Publikováno v:
Modern Pathology. 35:697-704
Testicular adult granulosa cell tumor (AGCT) is a rare type of sex-cord stromal tumor that affects patients of a wide age range and has the potential for late metastasis. In the testis, the diagnosis of AGCTs often requires the exclusion of other mor
Autor:
Alexander Zaslavsky, Andi K. Cani, Chia Jen Liu, Simpa S. Salami, Judith Stangl-Kremser, Randy Vince, Rohit Mehra, Razeen Karim, Ganesh S. Palapattu, Todd M. Morgan, Trinh Pham, Christopher M. Russell, Srinivas Nallandhighal, Aaron M. Udager, Kevin Hu, Marcin Cieslik, Skylar Groves
Publikováno v:
European Urology Oncology. 5:92-99
Background There is an ongoing need to develop prognostic biomarkers to improve the management of clear cell renal cell carcinoma (ccRCC). Objective To leverage enriched pathways in ccRCC to improve risk-stratification. Design, setting, and participa
TERT Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract
Autor:
Alexander S. Taylor, Brandon Newell, Arul M. Chinnaiyan, Khaled S. Hafez, Alon Z. Weizer, Daniel E. Spratt, Anne P. Cameron, Hikmat A. Al-Ahmadie, Sounak Gupta, Jeffrey S. Montgomery, Bryan L. Betz, Noah Brown, Rohit Mehra
Publikováno v:
European Urology Open Science
We identified urothelial tract biopsy and resection specimens with keratinizing squamous metaplasia (KSM), nonkeratinizing squamous metaplasia (NKSM), and urothelial and squamous carcinomas over a 20-yr period, focusing on cases with neurogenic lower
Publikováno v:
Asian Journal of Urology, Vol 9, Iss 1, Pp 1-11 (2022)
Chromophobe renal cell carcinoma (ChRCC) is the third most common renal cell carcinoma (RCC) subtype, which predominantly occurs in sporadic setting. ChRCCs are considered to originate from the intercalated cell of distal tubules with two main morpho
Autor:
Rohit Mehra, Tanmay Shah, Chia-Jen Liu, Komal R. Plouffe, Xiaoming Wang, Rahul Mannan, Xuhong Cao, Arul M. Chinnaiyan, Scott A. Tomlins, Aaron M. Udager
Publikováno v:
Modern Pathology. 36:100146
Autor:
George J. Netto, Kiril Trpkov, Ming Zhou, Reza Alaghehbandan, Fiona Maclean, Ying-Bei Chen, Liang Cheng, Sean R. Williamson, Cristina Magi-Galluzzi, Steven C. Smith, Virginie Verkarre, Huiying He, Michelle S. Hirsch, Santosh Menon, Jesse K. McKenney, Anthony J. Gill, Abbas Agaimy, Ondrej Hes, Rola Saleeb, Rajal B. Shah, Adebowale J. Adeniran, José I. López, Sounak Gupta, Payal Kapur, Fumiyoshi Kojima, Satish K. Tickoo, Victor E. Reuter, John C. Cheville, Maria S. Tretiakova, Jonathan I. Epstein, Christopher G. Przybycin, Isabela Werneck da Cunha, Qiu Rao, Sara E. Wobker, Mahul B. Amin, Eva Compérat, Jennifer B. Gordetsky, Pedram Argani, Peter A. Humphrey, Rohit Mehra, Lawrence D. True, Priya Rao
Publikováno v:
Modern Pathology. 34:1392-1424
The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide an update on existing entities, including diagnostic criteria, molecular correla